Skip to main content

Epidemiological Aspects: Prevalence and Risk of Heart Failure Related to Blood Pressure

  • Chapter
  • First Online:
Hypertension and Heart Failure

Abstract

Heart failure (HF) is a common, highly morbid, and costly clinical syndrome with a growing impact on global public health. The increase in HF prevalence in high-income countries is related to the aging of populations, whereas in middle- and low-income countries, it is also related to the increasing burden of hypertension and other cardiovascular risk factors. Hypertension is the most prevalent risk factor for HF. In high-income countries, hypertension, together with arrythmias and coronary artery disease, carries the highest population-attributable risk of HF. In low-income countries, hypertension and rheumatic heart disease play the main role in HF development. Approximately 40% of HF cases in men and 60% in women can be attributed to hypertension. The risk of HF attributable to hypertension is twofold higher in patients with a preserved ejection fraction (EF) as compared to those with a reduced ejection fraction. The absence of hypertension, obesity, and diabetes substantially prolongs HF-free survival and life expectancy. Treatment of hypertension, particularly in individuals aged over 60 years, is associated with the greatest reduction of HF compared to other cardiovascular events. The risk of heart failure decreases by 24% for each 5-mmHg reduction in systolic blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McDonagh TA, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–726.

    Article  CAS  Google Scholar 

  2. Cleland JG, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338–45.

    Article  CAS  Google Scholar 

  3. Abdul-Rahim AH, et al. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. Eur J Heart Fail. 2018;20(7):1139–45.

    Article  CAS  Google Scholar 

  4. Cleland JGF, et al. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2018;39(1):26–35.

    Article  CAS  Google Scholar 

  5. Silverman MG, et al. Impact of race, ethnicity, and multimodality biomarkers on the incidence of new-onset heart failure with preserved ejection fraction (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2016;117(9):1474–81.

    Article  Google Scholar 

  6. Hsu JJ, Ziaeian B, Fonarow GC. Heart failure with mid-range (borderline) ejection fraction: clinical implications and future directions. JACC Heart Fail. 2017;5(11):763–71.

    Article  Google Scholar 

  7. Triposkiadis F, et al. The continuous heart failure spectrum: moving beyond an ejection fraction classification. Eur Heart J. 2019;40(26):2155–63.

    Article  Google Scholar 

  8. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.

    Google Scholar 

  9. Benjamin EJ, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.

    Article  Google Scholar 

  10. Störk S, et al. Epidemiology of heart failure in Germany: a retrospective database study. Clin Res Cardiol. 2017;106(11):913–22.

    Article  Google Scholar 

  11. Conrad N, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572–80.

    Article  Google Scholar 

  12. van Riet EES, et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18(3):242–52.

    Article  Google Scholar 

  13. Rapsomaniki E, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383(9932):1899–911.

    Article  Google Scholar 

  14. Bleumink GS, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: the Rotterdam study. Eur Heart J. 2004;25(18):1614–9.

    Article  Google Scholar 

  15. Bursi F, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296(18):2209–16.

    Article  CAS  Google Scholar 

  16. Owan TE, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–9.

    Article  CAS  Google Scholar 

  17. Vasan RS, et al. Epidemiology of left ventricular systolic dysfunction and heart failure in the Framingham study: an echocardiographic study over 3 decades. JACC Cardiovasc Imaging. 2017;11(1):1–11.

    Article  Google Scholar 

  18. Bahrami H, et al. Differences in the incidence of congestive heart failure by ethnicity: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2008;168(19):2138–45.

    Article  Google Scholar 

  19. Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128(10):1421–34.

    Article  CAS  Google Scholar 

  20. Heidenreich PA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–19.

    Article  CAS  Google Scholar 

  21. Rowley WR, et al. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag. 2017;20(1):6–12.

    Article  Google Scholar 

  22. Christiansen MN, et al. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation. 2017;135(13):1214–23.

    Article  Google Scholar 

  23. Barasa A, et al. Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden. Eur Heart J. 2014;35(1):25–32.

    Article  Google Scholar 

  24. Yusuf S, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–27.

    Article  CAS  Google Scholar 

  25. Dokainish H, et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Global Health. 2017;5(7):e665–72.

    Article  Google Scholar 

  26. Callender T, et al. Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2014;11(8):e1001699.

    Article  Google Scholar 

  27. Vos T, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.

    Article  Google Scholar 

  28. Mills KT, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–50.

    Article  Google Scholar 

  29. Jhund PS, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119(4):515–23.

    Article  Google Scholar 

  30. Yeung DF, et al. Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007. CMAJ. 2012;184(14):E765–73.

    Article  Google Scholar 

  31. Gerber Y, et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000-2010. JAMA Intern Med. 2015;175(6):996–1004.

    Article  Google Scholar 

  32. Taylor CJ, et al. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000–2017: population based cohort study. BMJ. 2019;364:l223.

    Article  Google Scholar 

  33. Sidney S, et al. Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015. BMC Cardiovasc Disord. 2017;17(1):192.

    Article  Google Scholar 

  34. Dunlay SM, et al. Risk factors for heart failure: a population-based case-control study. Am J Med. 2009;122(11):1023–8.

    Article  Google Scholar 

  35. Levy D, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557–62.

    Article  CAS  Google Scholar 

  36. Chamberlain AM, et al. Risk factors for heart failure in the community: differences by age and ejection fraction. Am J Med. 2020;133(6):e237–48.

    Article  Google Scholar 

  37. Butler J, et al. Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study. Heart. 2011;97(16):1304–11.

    Article  Google Scholar 

  38. Chirinos JA, et al. Late systolic central hypertension as a predictor of incident heart failure: the Multi-ethnic Study of Atherosclerosis. J Am Heart Assoc. 2015;4(3):e001335.

    Article  Google Scholar 

  39. Wohlfahrt P, et al. Aortic waveform analysis to individualize treatment in heart failure. Circ Heart Fail. 2017;10(2):e003516.

    Article  Google Scholar 

  40. Verdecchia P, et al. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Eur Heart J. 2009;30(6):679–88.

    Article  CAS  Google Scholar 

  41. Ahmad FS, et al. Hypertension, obesity, diabetes, and heart failure-free survival: the cardiovascular disease lifetime risk pooling project. JACC Heart Fail. 2016;4(12):911–9.

    Article  Google Scholar 

Download references

Funding

This work was supported by the Ministry of Health of the Czech Republic, Grant Number NV 19-09-00125.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wohlfahrt, P., Cífková, R. (2023). Epidemiological Aspects: Prevalence and Risk of Heart Failure Related to Blood Pressure. In: Dorobantu, M., Voicu, V., Grassi, G., Agabiti-Rosei, E., Mancia, G. (eds) Hypertension and Heart Failure. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-031-39315-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-39315-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-39314-3

  • Online ISBN: 978-3-031-39315-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics